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Background: Ankle-brachial pressure index (ABI) is a simple, inexpensive, and useful tool in the detection of peripheral
arterial occlusive disease (PAD). The current guidelines published by the American Heart Association define ABI as the
quotient of the higher of the systolic blood pressures (SBPs) of the two ankle arteries of that limb (either the anterior
tibial artery or the posterior tibial artery) and the higher of the two brachial SBPs of the upper limbs. We hypothesized
that considering the lower of the two ankle arterial SBPs of a side as the numerator and the higher of the brachial SBPs
as the denominator would increase its diagnostic yield.
Methods: The former method of eliciting ABI was termed as high ankle pressure (HAP) and the latter low ankle pressure
(LAP). ABI was assessed in 216 subjects and calculated according to the HAP and the LAP method. ABI findings were
confirmed by arterial duplex ultrasonography. A significant arterial stenosis was assumed if ABI was <0.9.
Results: LAP had a sensitivity of 0.89 and a specificity of 0.93. The HAP method had a sensitivity of 0.68 and a specificity
of 0.99. McNemar’s test to compare the results of both methods demonstrated a two-tailed P< .0001, indicating a highly
significant difference between both measurement methods.
Conclusions: LAP is the superior method of calculating ABI to identify PAD. This result is of great interest for
epidemiologic studies applying ABI measurements to detect PAD and assessing patients’ cardiovascular risk. ( J Vasc
Surg 2006;44:531-6.)Atherosclerosis is the leading cause of peripheral arte-
rial disease (PAD), and the presence of PAD is a marker of
a generalized atherosclerotic burden.1-3 Patients with PAD
often have coexisting coronary artery and cerebrovascular
disease.3-5 About half of PAD patients are asymptomatic6,7
and most patients die of atherothrombotic complications,
such as myocardial infarction or stroke, rather than from
the complications of PAD.6,7 The overall life expectancy is
decreased and cardiovascular and all-cause mortality is in-
creased in patients with PAD compared with controls.8,9
Measurement of the ankle-brachial pressure index
(ABI), also known as ankle-brachial index or ankle-arm
index, is easy to perform and allows for diagnosis and
further definition of the severity of peripheral arterial oc-
clusive disease.10-12 Its further objectives are to identify
patients at increased risk for cardiovascular events.13
According to a consensus conference report,14 ABI is
defined as the quotient of the higher of the systolic blood
pressures (SBPs) of the two ankle arteries (either the ante-
rior tibial artery or the posterior tibial artery) and the
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doi:10.1016/j.jvs.2006.05.016average of the right and left brachial artery pressures, unless
the discrepancy is 10 mm Hg in blood pressure values
between the two arms. In such a case, the higher reading is
used for the ABI.
Remarkably, the current American Heart Association
(AHA) guideline does not specify whether to use the higher
or lower of the two ankle arterial systolic pressures.15 This
might explain why ABI was calculated quite inconsistently
in previous studies, leaving a direct comparison of these
results a difficult task.9,16-18 Thus, these results are hardly
comparable, and evaluation of the most sensitive method
for ABI is warranted.
Although the currently recommended method of cal-
culating ABI is useful to characterize the severity of PAD, it
might bear significant shortcomings for PAD screening,
because obstructions of single infrageniculate arteries will
not influence ABI. Thus, we hypothesized that considering
the lower of the two ankle arterial SBPs of a side as the
numerator and the higher of the brachial SBP as the de-
nominator would increase the sensitivity to detect PAD,
particularly in asymptomatic patients.
METHODS
Study design. The study was conducted at the outpa-
tient clinic of the Department of Vascular Medicine of
Klinikum Karlsbad-Langensteinbach, an affiliated teaching
hospital of the University of Heidelberg, Germany. The
cohort consisted of patients aged 40 years suspected of
having a vascular disease who presented at the outpatient
clinic from August to November 2004. Exclusion criteria
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amputations proximal to the heads of metatarsals of one or
both lower limbs and amputations proximal to the wrist
one or both arms, (3) limb wounds or ulcerations proximal
to the metatarsal heads in the lower limbs, (4) prior bypass
surgery to the lower limb arteries or prosthetic vascular
reconstructions of the abdominal aorta and subclavian/
axillary arteries, or angioplasty, (5) marked edema of one or
both feet as well as edema of both arms, (6) acute limb
ischemia, (7) body mass index (BMI)40, (8) atrial fibril-
lation, (9) ABI 1.3 in both lower limbs, and (10) a poor
sonographic window of the abdomen or the lower limb
arteries. Participants with a unilaterally elevated ABI were
included and the limb with normal or diminished ABI was
evaluated. Ethics committee approval was not obtained
because all measurements were performed on a regular
clinical basis.
All subjects underwent ABI measurement followed by
color-coded duplex ultrasound (CCDU) of the lower limb
arterial system as described in the next section. Serial con-
trast enhanced intra-arterial digital substraction angiogra-
phy (DSA) was not included in the core of the study
because of ethical considerations; however, the angio-
graphic results in subjects with established symptomatic
PAD who underwent DSA or endovascular revasculariza-
tion at the same institution were correlated with the find-
ings of ABI and CCDU to confirm the diagnostic value of
CCDU.
Ankle-brachial index measurement. For measure-
ment of ABI, a sphygmomanometer (Erka GmbH, Bad
Toelz, Germany) with a cuff width range of 29 to 40 cm
and a Doppler device (Ultrasonic Flow Detector model
811-B, Parks Medical Electronic Inc, Aloha, Ore) with an
8.2 MHz continuous wave probe was used (Fig 1).
ABI was measured according to the method described
by Lovelace and Moneta.19 It was performed by two exam-
iners with an experience of3000 ABI measurements who
were blinded to all clinical baseline parameters assessed.
ABI values were then calculated applying two different
methods (Fig 1):
The higher ankle SBP was used for the higher ankle
pressure (HAP) method, and the lower ankle SBP was used
as the numerator for the lower ankle pressure (LAP)
method. For descriptive purposes, the study subjects were
assigned into three groups according to the results of ABI
measurements byHAP and LAPmethods. Group 1 subjects
had an ABI 0.9 as assessed by both methods, group II
subjects had an ABI0.9 as assessed by both methods, and
group III subjects had an ABI 0.9 by the LAP method
but not by the HAP method.
Color-coded duplex ultrasonography of the lower
limb arteries. CCDU was performed using a HDI 5000
ultrasound device (Advanced Technology Laboratories,
Bothell, Wash) by two sonographers (A. P, U. Z.) with an
experience of 2000 lower limb examinations who were
blinded to all clinical baseline parameters assessed. A sector
array probe of 2 to 4 MHz was used to scan the abdominal
aorta and iliac arteries. A linear array probe of 4 to 7 MHzwas used to scan the femoral, popliteal, and proximal
segments of the infrageniculate arteries. The mid and distal
segments of the infrageniculate arteries were scanned by a
7- to 10-MHz linear array probe. Color flow Doppler was
used to guide the placement of the sample volume of pulse
wave Doppler. Scanning commenced from the abdominal
aorta at the xiphoid process and included assessment of
lower limb arteries down to the dorsum of the foot accord-
ing to the scanning methodology described by Allen et al.20
Hemodynamically relevant stenosis (70% to 99%) of an
arterial segment was defined as an increase in peak velocity
ratio of 2.21 An arterial segment was considered occluded
when there was no filling of the vessel with the color signal
in color flow Doppler, no spectral signal on pulse wave
Doppler, and a complete absence of flow with power
Doppler.
To quantify CCDU findings, the arterial tree examined
was divided into 23 segments as proposed by Wilting.22
Briefly, the first three segments included the suprarenal and
infrarenal aorta as well as the aortic bifurcation. Segments
four to 13 described the arterial tree from the common iliac
artery to the distal segment of the popliteal artery. Seg-
ments 14 to 23 comprised the proximal, mid, and distal
Fig 1. Measurement of ABI as per the current protocol, the HAP
method: ABI of right side  higher of the right ankle arterial SBP
(mm Hg)/higher of the two brachial SBP (mm Hg). ABI of left
side higher of the left ankle arterial SBP (mmHg)/higher of the
two brachial SBP (mm Hg). Measurement of ABI by the LAP
method: ABI of right side lower of the two right ankle SBP (mm
Hg)/higher of the two brachial SBP (mm Hg). ABI of left side 
lower of the two left ankle SBP (mm Hg)/higher of the two
brachial SBP (mm Hg).sections of the three infrageniculate arteries.
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of obstruction within each arterial segment. The letter A
was used to describe the absence of hemodynamically rele-
vant flow-limiting stenosis, and B was used to describe the
presence of hemodynamically relevant flow-limiting steno-
sis. This characterization was subdivided into B1 (presence
of a single hemodynamically relevant stenosis) and B2
(presence of more than one hemodynamically relevant
stenosis). The letter C described the presence of arterial
occlusion.
The abdominal aorta was considered aneurysmal when
its diameter was 3 cm. For the common iliac arteries, a
vessel diameter of 1.7 cm was considered aneurysmal.
Diameter of1.5 cm was considered aneurysmal for exter-
nal iliac and femoral arteries. The diameter to demarcate
aneurysmal dilation in the popliteal arteries was 1.3 cm.
In the infrageniculate arteries, a diameter of 1 cm was
considered aneurysmal.
Digital subtraction angiography. Intra-arterial DSA
was performed and assessed by consensus agreement by
two experienced readers (U. Z., H. L.) who were blinded
to clinical and CCDU data. The findings in patients in
whom additional DSA was available were reported accord-
ing to the method described for assessment of CCDU
findings, and clinically relevant binary stenosis was defined
as a 50% diameter reduction by visual estimation.
After the results of ABI and CCDU were correlated,
the patients were designated to one of the six subgroups.
They were designated I to III and the letters A or B added
as the suffix according to the findings of CCDU. The leg
with the lower ABI was the index leg for the following
specifications:
● Subgroup IA: patients with ABI 0.9 by both meth-
ods and with no evidence of PAD on CCDU (ie, true
negative for PAD).
● Subgroup IB: patients with ABI 0.9 by both meth-
ods but with positive evidence of PAD on CCDU ie,
false negative for PAD.
● Subgroup IIA: patients with ABI 0.9 by both meth-
ods and with positive evidence of PAD by CCDU (ie,
true positive for PAD by both methods).
● Subgroup IIB: patients with ABI 0.9 by both meth-
ods but no evidence of PAD by CCDU (ie, false
positive for PAD by both methods).
● Subgroup IIIA: patients with ABI 0.9 by LAP
method but 0.9 by HAP method with positive evi-
dence of PAD by CCDU (true positive for PAD by
LAP method but false negative by HAP method).
● Subgroup IIIB: patients with ABI 0.9 by LAP
method but 0.9 by HAP method without evidence
of PAD by CCDU (ie, false positive for PAD by LAP
method but true negative for PAD by HAP).
Statistical methods. Categoric variables were ex-
pressed in numbers and percentages and continuous vari-
ables in absolute numbers and percentages. Pearson’s
method was used to express the coefficient of correlation
between the findings of x-ray contrast angiography andCCDU. The prevalence of PAD and the sensitivity, speci-
ficity, positive and negative predictive values, and diagnos-
tic odds ratios of both measurement modalities were as-
sessed, with duplex ultrasound being the standard of
reference for the presence of significant arterial obstruc-
tions. McNemar’s test was used as a nonparametric test of
matched pairs of labels to determine whether the diagnosis
PAD according to the HAP and the LAP methods was
significantly different. The null hypothesis was the presence
of an equal diagnostic yield of HAP and LAP.
RESULTS
Demography. Four of the 237 patients initially will-
ing to participate in this study were excluded because of
atrial fibrillation, three were excluded for a BMI 40, six
were excluded because their ABIs were1.3 in both lower
limbs, and eight were excluded owing to poor abdominal
sonographic windows. In total, 216 participants were eligi-
ble for enrollment in this study, of which 139 (64.4%) were
men and 77 (35.6%) were women. The mean patient age
was 64.4 years (median, 65 years).
Of the 216 patients examined, 81 (37.5%) had inter-
mittent claudication (44 at Fontaine stage IIa and 35 at
Fontaine stage IIB), 74 (34.3%) had diabetes mellitus, 65
(30.1%) were current smokers, 47 (21.8%) were previous
smokers, 165 (76.4%) had hypertension, and 143 (66.2%)
had dyslipidemia.
Color-coded duplex ultrasonography of lower limb
arteries. Duplex ultrasound was used to evaluate 9288
arterial segments, of which 148 (1.6%) were occluded, 893
(9.6%) had relevant stenoses, and 183 (1.9%) had nonsig-
nificant stenoses. Eighty (54.4%) of 147 occluded seg-
ments, 555 (62.2%) of 893 significantly stenosed segments,
and 85(46.4%) of 183 nonsignificantly stenosed segments
were located in the infrageniculate arteries. Significant ste-
noses as diagnosed by duplex ultrasound that did not result
in significant reduction of ABI was found in 43 (0.5%) of
9288 segments. Of the seven patients we detected with
aneurysmal disease, six had abdominal aneurysms and one
had an isolated femoropopliteal aneurysm.
Ankle-brachial pressure index. ABI was calculated
for all 216 patients (ie, for all 432 limbs by HAP as well
as by LAP method), and 109 (51%) were in group I
(ABI 0.9 as assessed by both methods), 78 (36%) were
in group II (ABI 0.9 as assessed by both methods) and
29 (13%) were in group III (ABI 0.9 by LAP method
but not by HAP method). As postulated, group III con-
sisted of 18 subjects with CCDU diagnosis of PAD re-
stricted to infrageniculate arteries, four had a combined
PAD of infrageniculate and iliacal/femoropopliteal arter-
ies, and only one patient had a stenosis of the superficial
femoral artery without obstruction of infrageniculate arter-
ies in CCDU. Six patients were positive according to LAP;
however, CCDU revealed no relevant arterial obstruction
in these patients.
X-ray contrast angiography of lower limb arteries.
Forty-two (19.4%) of 216 patients underwent additional
DSA. Angiographically, 439 segments were significantly
le pres
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stenotic segments on angiography. Overall, there was a
good correlation between angiography and CCDU find-
ings, the coefficient of correlation (r) was 0.9533.
Validation of high and low ankle pressure methods.
Correlation of HAP and LAP measurements with CCDU
findings is given in Table I. According to CCDU, 52% of
patients in this cohort had PAD. The sensitivity to detect
PAD using the HAP method was 0.68 and the specificity
was 0.99 (Fig 2). The positive predictive value was 0.99 and
he negative predictive value was 0.74. In this cohort, we
found 13 (6%) of 216 patients with false-negative results
(compare Table I). Effectively, two patients with claudica-
tion were not picked up by HAP and LAP.
The sensitivity to detect PAD using the LAP method
was increased to 0.89, whereas the specificity modestly
declined to 0.93 (Fig). The positive predictive value was
0.93 and the negative predictive value was 0.88 (Table II).
McNemar’s test to compare the results of the two
methods demonstrated a two-tailed P  .0001, indicating
a highly significant difference between the two measure-
ment methods.
DISCUSSION
An important aim of ABI measurement is detection of
PAD in asymptomatic patients to define the individual
cardiovascular risk enhancing the stratification of the need
for primary prevention.23-26 Thus, definitions on how to
Fig 2. Sensitivity and specificity of the ankle-brachial index calcu-
lated by the high ankle pressure method (HAP) and the low ankle
pressure method (LAP) method compared with the results of
Table I. Descriptive subgroups of subjects correlating the
duplex ultrasonography
Group
ABI by HAP
method
ABI by LAP
method PAD on CCDU
IA Normal Normal Absent
IB Normal Normal Present
IIA Diminished Diminished Present
IIB Diminished Diminished Absent
IIIA Normal Diminished Present
IIIB Normal Diminished Absent
ABI,Ankle-brachial pressure index;HAP, high ankle pressure; LAP, low ank
occlusive disease.color-coded duplex ultrasonography.calculate ABI are subject to significant variations. Because
the current AHA guideline does not specify whether to use
the higher or lower of the two ankle arterial systolic pres-
sures,15 ABI was calculated quite inconsistently in previous
studies. For instance, some investigators assessed no more
than the posterior tibial artery,9,16 some used the mean
systolic pressure,17 and some used the higher systolic pres-
sure of the brachial arteries as the denominator.16 Resnick
et al9 assessed only the right arm blood pressure. In another
epidemiologic study, the systolic ankle pressure was mea-
sured in the supine position and the systolic brachial-
pressure in a sitting position.18 Thus, these results are
hardly comparable, and evaluation of the most sensitive
method for ABI is warranted.
We have shown that by a simple modification, namely
considering the lower of the ankle pressures measured, the
sensitivity of ABImeasurement to detect patients with PAD
can be substantially increased without any further effort and
expenditure for the examiner. In the present study, sensi-
tivity of the HAP method to detect PAD within a patient
was 68%. In contrast, previous articles reported a sensitivity
of approximately 90% for this conventional method of ABI
measurement.27,28 The reason for the low sensitivity of
HAP could be the high proportion of diabetic patients in
the group we studied. Medial calcinosis in these patients
might have led to overestimation of the lower limb pressure.
Our data are, however, in line with recent reports also
lts of ankle brachial pressure index and color-coded
Description
No. of patients
(n  216)
e negative for PAD 96 (44%)
se negative for PAD 13 (6%)
e positive for PAD by both methods 77 (36%)
se positive for PAD by both methods 1 (0.5%)
e positive by LAP and false negative by HAP 23 (11%)
se positive by LAP and true negative by HAP 6 (3%)
sure;CCDU, color-coded duplex ultrasonography; PAD, peripheral arterial
Table II. Validation of the high ankle pressure method
and low ankle pressure method
HAP method (%) LAP method (%)
True negatives for PAD 102 (47) 96 (44)
False negatives for PAD 36 (17) 13 (6)
True positives for PAD 77 (36) 100 (46)
False positives for PAD 1 (0.5) 7 (3)
Sensitivity 0.68 0.89
Specificity 0.99 0.93
Positive predictive value 0.99 0.93
Negative predictive value 0.74 0.88
HAP, High ankle pressure; LAP, low ankle pressure; PAD, peripheral
arterial occlusive disease.resu
Tru
Fal
Tru
Fal
Tru
Faldescribing a considerably lower sensitivity of the conven-
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HAP, the LAP method increased the sensitivity to detect
PAD to 89%. Conversely, specificity was only modestly
decreased. Notably, the LAP method was greatly more
sensitive in patients with obstructed infrageniculate arter-
ies. In 22 of 23 PAD-patients detected by LAP but not by
theHAPmethod, CCDU revealed a significant obstruction
of the infrageniculate arteries.
Several shortcomings of our study have to be ad-
dressed. Although a good correlation between angiography
and CCDU findings was observed and a good intermodal-
ity agreement has been reported by others,32 DSA imaging,
being the gold standard, was available in no more than one
fifth of patients. In addition, angiograms were not analyzed
using quantification tools such as calipers or dedicated
software analyses.
Because the subjects in this study were not followed-
up, our study is unable to define the prognostic implica-
tions of PAD using the proposed LAP measurement
method to calculate ABI. However, subjects with normal
ABI but greatly reduced or absent flow in the posterior
tibial artery had elevated mortality compared with controls,
giving allusion that isolated PAD of infrageniculate arteries
may also be marker of increased cardiovascular risk.33
CONCLUSION
We demonstrated that implementing the lower ankle
pressure in the measurement of ABI is far more sensitive
than the conventional method, with a modest decline of
specificity compared with CCDU. The prognosis of PAD
defined according to the lower ankle pressure method for
calculation of ABI merits further investigation in prospec-
tive randomized trials. For decades, ABI has been used to
diagnose PAD. Nevertheless, because today ABI is increas-
ingly applied as a screeningmethod to define cardiovascular
risk, assessment of ABI has to be re-evaluated, exactly
redefined and standardized. (Fig 2).
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